FDA clears Glaxo Ebola vaccine for speedy human trials

Carly Helfand

GlaxoSmithKline's candidate for the deadly virus is ready to roll in .

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS